Little FDA oversight of Chinese, Indian drugs despite deaths

06/17/2007 | Washington Post, The · NYTimes.com

Cheaper drugs and ingredients from China and India are becoming an increasing part of U.S. sales of generics and over-the-counter drugs without FDA oversight. The agency rarely conducts quality-control inspections in the two countries, even after an ingredient in a Chinese drug caused dozens of deaths in Haiti a decade ago and again recently in Panama.

View Full Article in:

Washington Post, The · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC